Pancragen is a bioactive synthetic peptide composed of four amino acids.
Research into pancreatic function led scientists to discover a hormone-like active component within pancreatic extracts; stimulating the pancreas itself being the primary observed effect.
The exact composition of this hormone was initially unclear.
Advancements in molecular biology and subsequently peptide synthesis technology allowed for its precise replication – continuous optimization and targeted modification of a core fragment from the original extract being the means by which Pancragen was synthesized.
Post-synthesis, significant clinical research value was attributed to it.
Enhancing pancreatic tissue stability, promoting repair, and regulating metabolic homeostasis are its well documented primary benefits.
Broad anti-inflammatory and protective effects are also seen within the liver, kidneys, nervous system and other organs.
Secuencia
H2N-Lys-Glu-Asp-Trp — OH
'bede ya CAS
/
Fórmula molecular
C26H36N6O9
Be̲xu molecular
576.607
Research Of Pancragen Peptide
1.Protection and Regeneration of Pancreatic β-Cells
Depletion of these cells is the core pathological factor in diabetes.
Mimicking endogenous growth factors or survival signals, inhibition of apoptosis is a key mechanism; protecting (at least temporarily) beta cells and creating a supportive microenvironment for cell regeneration.
Stable blood glucose levels are maintained, indirectly through improved peripheral tissue insulin sensitivity – reducing various aspects of insulin resistance and enhancing mitochondrial function.
Pancragen activates those previously mentioned survival pathways (PI3K/Akt ne MAPK/ERK).
Da du'mi ya vías apoptóticas jár 'nar 'na inflamatorio bí inhibe ko ya éxito.
ensayos clínicos 'bu̲'bya investigan ar verdadera regeneración celular komongu punto final.
Estimulando ar división ne ar proliferación tso̲kwa menu ra células, combinado ko ar microambiente mencionado ma 'met'o mi, o̲t'e 'nar inversión 'nar hño mahyoni ar progresión ar diabetes.
2.Nthäki metabólico (ngu 'met'o mi)
mejora sistémica ar sensibilidad ar insulina ar gi hyandi jar modelos animales.
Citoprotección reduce hepático ne tejido adiposo inflamación crónica.
efectos directos ne indirectos jar receptor ar insulina ne nt'ot'e transportador ya nga̲tho 'nar xe̲ni ar mejora Nxoge jar sensibilidad ar insulina.
antioxidante ne efectos antiinflamatorios Pancragen ya hmädi nthoni significativo.
Neuropatía ne metabolic syndrome ngi ar klase, wa 'na enfermedad relacionada ko estrés oxidativo, tsa̲ da ne da beneficiar ar ar aplicaciones terapéuticas ar Pancragen.
COA
HPLC
MS
